Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2010 Nov;32(10):1222-7.
doi: 10.1111/j.1365-2036.2010.04471.x. Epub 2010 Sep 23.

Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux

Affiliations
Meta-Analysis

Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux

J H Rubenstein et al. Aliment Pharmacol Ther. 2010 Nov.

Abstract

Background: Endoscopic screening has been proposed for patients with symptoms of gastro-oesophageal reflux disease (GERD) in the hope of reducing mortality from oesophageal adenocarcinoma. Assessing the net benefits of such a strategy requires a precise understanding of the cancer risk in the screened population.

Aim: To estimate precisely the association between symptoms of GERD and oesophageal adenocarcinoma.

Methods: Systematic review and meta-analysis of population-based studies with strict ascertainment of exposure and outcomes.

Results: Five eligible studies were identified. At least weekly symptoms of GERD increased the odds of oesophageal adenocarcinoma fivefold (odds ratio = 4.92; 95% confidence interval = 3.90, 6.22), and daily symptoms increased the odds sevenfold (random effects summary odds ratio = 7.40, 95% confidence interval = 4.94, 11.1), each compared with individuals without symptoms or less frequent symptoms. Duration of symptoms was also associated with oesophageal adenocarcinoma, but with very heterogeneous results, and unclear thresholds.

Conclusions: Frequent GERD symptoms are strongly associated with oesophageal adenocarcinoma. These results should be useful in developing epidemiological models of the development of oesophageal adenocarcinoma, and in models of interventions aimed at reducing mortality from this cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of study selection.
Figure 2
Figure 2
Forrest plot of association of weekly GERD symptoms with oesophageal adenocarcinoma. Odds ratios are for symptoms at least weekly vs. no symptoms or symptoms less than weekly. Scale is logarithmic.

References

    1. [Accessed July 15, 2008];Fast Stats: Esophagus Cancer. Available at: http://seer.cancer.gov/faststats/selections.php.
    1. Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer. 2001;92:549–55. - PubMed
    1. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–31. - PubMed
    1. Farrow DC, Vaughan TL, Sweeney C, et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control. 2000;11:231–8. - PubMed
    1. Wu AH, Tseng CC, Bernstein L. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer. 2003;98:940–8. - PubMed

Publication types

MeSH terms